Back to all studies
CompletedNCT01235520

RO4917838 for schizophrenia

This study is completed in the United States, in Australia, in France, .... It is testing RO4917838 for schizophrenia.

SchizophreniaDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether RO4917838 may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive RO4917838, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Argentina, in Australia, and in Colombia.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJanuary 2011
Recruitment status
Completed
Enrollment listed in the registry
595
Sponsor
Hoffmann-La Roche
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Australia, France, ...
Age range
Over 18 Years
Official registry ID
NCT01235520
Official title
Phase III, Multi-center, Randomized, 12-week, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 40-week Double-blind, Parallel-group, Placebo-controlled Treatment Period.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Argentina · 10 sites
  • Buenos Aires
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Buenos Aires
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Ciudad Autonoma Bs As
    Ciudad Autonoma Bs As
    Site status: Not listed — confirm with the team
  • Ciudad Autonoma Bs As
    Ciudad Autonoma Bs As
    Site status: Not listed — confirm with the team
  • Córdoba
    Córdoba
    Site status: Not listed — confirm with the team
  • Córdoba
    Córdoba
    Site status: Not listed — confirm with the team
  • La Plata
    La Plata
    Site status: Not listed — confirm with the team
  • Mendoza
    Mendoza
    Site status: Not listed — confirm with the team
  • Rosario
    Rosario
    Site status: Not listed — confirm with the team
  • Santiago del Estero
    Santiago del Estero
    Site status: Not listed — confirm with the team
Australia · 4 sites
  • Westmead
    Westmead, New South Wales
    Site status: Not listed — confirm with the team
  • Clayton
    Clayton, Victoria
    Site status: Not listed — confirm with the team
  • Frankston
    Frankston, Victoria
    Site status: Not listed — confirm with the team
  • Melbourne
    Melbourne, Victoria
    Site status: Not listed — confirm with the team
Colombia · 3 sites
  • Barranquilla
    Barranquilla
    Site status: Not listed — confirm with the team
  • Bello
    Bello
    Site status: Not listed — confirm with the team
  • Bogotá
    Bogotá
    Site status: Not listed — confirm with the team
Finland · 2 sites
  • Helsinki
    Helsinki
    Site status: Not listed — confirm with the team
  • Kuopio
    Kuopio
    Site status: Not listed — confirm with the team
France · 6 sites
  • Clermont-Ferrand
    Clermont-Ferrand
    Site status: Not listed — confirm with the team
  • Dole
    Dole
    Site status: Not listed — confirm with the team
  • Élancourt
    Élancourt
    Site status: Not listed — confirm with the team
  • Marseille
    Marseille
    Site status: Not listed — confirm with the team
  • Strasbourg
    Strasbourg
    Site status: Not listed — confirm with the team
  • Toulon
    Toulon
    Site status: Not listed — confirm with the team
Hungary · 6 sites
  • Balassagyarmat
    Balassagyarmat
    Site status: Not listed — confirm with the team
  • Budapest
    Budapest
    Site status: Not listed — confirm with the team
  • Budapest
    Budapest
    Site status: Not listed — confirm with the team
  • Budapest
    Budapest
    Site status: Not listed — confirm with the team
  • Győr
    Győr
    Site status: Not listed — confirm with the team
  • Gyula
    Gyula
    Site status: Not listed — confirm with the team
India · 12 sites
  • Ahmedabad
    Ahmedabad
    Site status: Not listed — confirm with the team
  • Ahmedabad
    Ahmedabad
    Site status: Not listed — confirm with the team
  • Ahmedabad
    Ahmedabad
    Site status: Not listed — confirm with the team
  • Bangalore
    Bangalore
    Site status: Not listed — confirm with the team
  • Jaipur
    Jaipur
    Site status: Not listed — confirm with the team
  • Jaipur
    Jaipur
    Site status: Not listed — confirm with the team
  • Kalyān
    Kalyān
    Site status: Not listed — confirm with the team
  • Mangalore
    Mangalore
    Site status: Not listed — confirm with the team
  • Mangalore
    Mangalore
    Site status: Not listed — confirm with the team
  • Nashik
    Nashik
    Site status: Not listed — confirm with the team
  • Pune
    Pune
    Site status: Not listed — confirm with the team
  • Vadodara
    Vadodara
    Site status: Not listed — confirm with the team
Mexico · 5 sites
  • México
    México
    Site status: Not listed — confirm with the team
  • Monterrey
    Monterrey
    Site status: Not listed — confirm with the team
  • Monterrey
    Monterrey
    Site status: Not listed — confirm with the team
  • Monterrey
    Monterrey
    Site status: Not listed — confirm with the team
  • San Luis Potosí City
    San Luis Potosí City
    Site status: Not listed — confirm with the team
Romania · 8 sites
  • Arad
    Arad
    Site status: Not listed — confirm with the team
  • Bucharest
    Bucharest
    Site status: Not listed — confirm with the team
  • Bucharest
    Bucharest
    Site status: Not listed — confirm with the team
  • Cluj-Napoca
    Cluj-Napoca
    Site status: Not listed — confirm with the team
  • Lasi
    Lasi
    Site status: Not listed — confirm with the team
  • Oradea
    Oradea
    Site status: Not listed — confirm with the team
  • Sibiu
    Sibiu
    Site status: Not listed — confirm with the team
  • Targouiste
    Targouiste
    Site status: Not listed — confirm with the team
Russia · 18 sites
  • Kemerovo
    Kemerovo
    Site status: Not listed — confirm with the team
  • Lipetsk
    Lipetsk
    Site status: Not listed — confirm with the team
  • Moscow
    Moscow
    Site status: Not listed — confirm with the team
  • Moscow
    Moscow
    Site status: Not listed — confirm with the team
  • Moscow
    Moscow
    Site status: Not listed — confirm with the team
  • Moscow
    Moscow
    Site status: Not listed — confirm with the team
  • Moscow Region
    Moscow Region
    Site status: Not listed — confirm with the team
  • Nizhny Novgorod
    Nizhny Novgorod
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Samara
    Samara
    Site status: Not listed — confirm with the team
  • Sartatov
    Sartatov
    Site status: Not listed — confirm with the team
  • Talagi
    Talagi
    Site status: Not listed — confirm with the team
  • Tomsk
    Tomsk
    Site status: Not listed — confirm with the team
South Korea · 9 sites
  • Busan
    Busan
    Site status: Not listed — confirm with the team
  • Gwangju
    Gwangju
    Site status: Not listed — confirm with the team
  • Gyeonggi-do
    Gyeonggi-do
    Site status: Not listed — confirm with the team
  • Incheon
    Incheon
    Site status: Not listed — confirm with the team
  • Incheon
    Incheon
    Site status: Not listed — confirm with the team
  • Jeollabuk-do
    Jeollabuk-do
    Site status: Not listed — confirm with the team
  • Seoul
    Seoul
    Site status: Not listed — confirm with the team
  • Seoul
    Seoul
    Site status: Not listed — confirm with the team
  • Seoul
    Seoul
    Site status: Not listed — confirm with the team
Sweden · 4 sites
  • Malmö
    Malmö
    Site status: Not listed — confirm with the team
  • Stockholm
    Stockholm
    Site status: Not listed — confirm with the team
  • Stockholm
    Stockholm
    Site status: Not listed — confirm with the team
  • Uppsala
    Uppsala
    Site status: Not listed — confirm with the team
United Kingdom · 4 sites
  • Edinburgh
    Edinburgh
    Site status: Not listed — confirm with the team
  • London
    London
    Site status: Not listed — confirm with the team
  • London
    London
    Site status: Not listed — confirm with the team
  • Oxford
    Oxford
    Site status: Not listed — confirm with the team
United States · 30 sites
  • Little Rock
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Little Rock
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Buena Park
    Buena Park, California
    Site status: Not listed — confirm with the team
  • Cerritos
    Cerritos, California
    Site status: Not listed — confirm with the team
  • Downey
    Downey, California
    Site status: Not listed — confirm with the team
  • La Palma
    La Palma, California
    Site status: Not listed — confirm with the team
  • Pasadena
    Pasadena, California
    Site status: Not listed — confirm with the team
  • Pico Rivera
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • Miami
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Miami
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Marietta
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Oak Brook
    Oak Brook, Illinois
    Site status: Not listed — confirm with the team
  • Iowa City
    Iowa City, Iowa
    Site status: Not listed — confirm with the team
  • Glen Burnie
    Glen Burnie, Maryland
    Site status: Not listed — confirm with the team
  • Las Vegas
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Toms River
    Toms River, New Jersey
    Site status: Not listed — confirm with the team
  • Willingboro
    Willingboro, New Jersey
    Site status: Not listed — confirm with the team
  • Albuquerque
    Albuquerque, New Mexico
    Site status: Not listed — confirm with the team
  • Brooklyn
    Brooklyn, New York
    Site status: Not listed — confirm with the team
  • Fresh Meadows
    Fresh Meadows, New York
    Site status: Not listed — confirm with the team
  • New York
    New York, New York
    Site status: Not listed — confirm with the team
  • Raleigh
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Cincinnati
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Philadelphia
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Scranton
    Scranton, Pennsylvania
    Site status: Not listed — confirm with the team
  • Bellaire
    Bellaire, Texas
    Site status: Not listed — confirm with the team
  • Dallas
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Dallas
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • The Woodlands
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Kirkland
    Kirkland, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01235520. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, RO4917838. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Hoffmann-La Roche, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me